Dexamethasone phosphate is a glucocorticoid.1 It reduces LPS-induced production of RANTES, TGF-β1, and nitric oxide (NO) in BV-2 microglia when used at concentrations ranging from 1 to 4 ?M. Dexamethasone phosphate reverses LPS-induced decreases in IL-10 levels in, and inhibits LPS-induced migration of, BV-2 microglia when used at a concentration of 4 ?M. In vivo, dexamethasone phosphate decreases motor activity and reduces adrenal weight and plasma corticosterone levels in rats when administered in the drinking water at a concentration of 5 ?g/ml.2 Dexamethasone phosphate (1.6 mg/kg per day) reduces joint swelling in a rat model of collagen-induced arthritis when administered for a minimum of seven days.3 It also reduces pruritis and the clinical lesion score in cats with hypersensitivity dermatitis.4 Formulations containing dexamethasone phosphate have been used in the treatment of various inflammatory diseases, arthritis, and endocrine disorders.
1.Hui, B., Yao, X., Zhang, L., et al.Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cellsNaunyn Schmiedebergs Arch. Pharmacol.393(9)1761-1768(2020) 2.Katz, R.J., and Carroll, B.J.Endocrine control of psychomotor activity in the rat: Effects of chronic dexamethasone upon general activityPhysiol. Behav.20(1)25-30(1978) 3.Rauchhaus, U., Schwaiger, F.W., and Panzner, S.Separating therapeutic efficacy from glucocorticoid side-effects in rodent arthritis using novel, liposomal delivery of dexamethasone phosphate: Long-term suppression of arthritis facilitates interval treatmentArthritis Res. Ther.11(6)R190(2009) 4.McClintock, D., Austel, M., Gogal, R.M., Jr., et al.Oral dexamethasone sodium phosphate solution significantly reduces pruritus and clinical lesions in feline hypersensitivity dermatitis: An open-label studyVet. Dermatol.32(5)497-e137(2021)
















